ASPEN: 10,101 -119 (-1.16%)
Aspen to split South African commercial pharmaceutical business
JOHANNESBURG, March 7 (Reuters) - Multinational drugmaker
Aspen Pharmacare said it will split its South African
Commercial Pharmaceuticals business into two distinct divisions
as part of a strategic review of its South African and European
Aspen, with a presence in 56 countries spanning six
continents, said on Thusday the split would improve its focus on
products and customers.
In its half-year results statement, it said a second phase
of the review would concentrate on developing strategies
specific to each division, although it did not say what the two
divisions would be.
(Reporting by Nqobile Dludla; Editing by Kirsten Donovan)
© 2019 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.